Related Experiment Videos
Gilles de la Tourette syndrome
1Department of Clinical Neurosciences, Faculty of Medicine, University of Calgary, Alberta, Canada.
Summary
Gilles de la Tourette syndrome is a neurological disorder affecting 1 in 1000 people, characterized by motor and vocal tics. Treatment involves education, counseling, and individualized medication for symptom management.
Area of Science:
- Neurology
- Genetics
Background:
- Gilles de la Tourette syndrome (GTS) is a neurological disorder.
- It is characterized by involuntary motor and vocal tics.
- Associated features include obsessive-compulsive behavior and attention-deficit disorder.
Purpose of the Study:
- To provide an overview of Gilles de la Tourette syndrome.
- To discuss its genetic transmission and potential neuropathophysiology.
- To outline current treatment approaches.
Main Methods:
- Review of existing literature on Tourette syndrome.
- Discussion of genetic inheritance patterns.
- Exploration of proposed neuropathophysiological mechanisms.
Main Results:
- GTS gene may be present in 1 in 1000 individuals, inherited as an autosomal dominant trait.
- Many carriers exhibit minimal symptoms.
- Neuropathophysiology is unknown, but basal ganglia receptor systems (dopaminergic, endorphin) are implicated.
Conclusions:
- GTS is more common than previously thought.
- Understanding genetic and neuropathophysiological factors is crucial.
- Individualized treatment combining education, counseling, and medication is essential for managing GTS manifestations.